The phosphoramidite market is projected to grow from USD 1.2 billion in 2025 to USD 2.7 billion by 2035, at a CAGR of 8.1%. DNA Phosphoramidites will dominate with a 36.1% market share, while drug discovery & development will lead the application outlook segment with a 54.1% share.